Intratumoral Heterogeneity of MAGED4 Expression in Oral Squamous Cell Carcinoma: Epigenetic Mechanisms and Therapeutic Implications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411772 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Huan Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, School of Basic Medicine Science, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Mouth Neoplasms, Gene Expression Regulation, Neoplastic, Carcinoma, Squamous Cell. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Guangxi Young and Middle-aged University Teachers’ Scientific Research Ability Enhancement Project.
Abstract (Originalsprache)
Intratumoral heterogeneity poses significant challenges to the efficacy of cancer immunotherapy. Melanoma-associated antigen D4 (MAGED4) has been proposed as a potential immunotherapeutic target in oral squamous cell carcinoma (OSCC). This study aims to investigate the expression of MAGED4, focusing on its intratumoral expression heterogeneity and the underlying epigenetic regulation mechanism. Utilizing public online databases, immunohistochemical analyses of clinical specimens, and single-cell RNA sequencing data, we found that MAGED4 was overexpressed with significant intratumoral heterogeneity in OSCC tissues. Methylation-promoter luciferase reporter assays revealed that MAGED4 transcription was suppressed by DNA methylation at its promoter region. Additionally, co-expression analysis implicated a potential role for histone acetylation in regulating MAGED4. To functionally validate these findings, we treated OSCC cells with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (DAC) and histone deacetylase inhibitors trichostatin A (TSA) and valproic acid (VPA). The triple-drug combination treatment resulted in the most robust reactivation of MAGED4 expression, correlating with promoter DNA demethylation and enhanced acetylation of H3K9 and H3K27 at the MAGED4 promoter. Our findings elucidate critical epigenetic mechanisms contributing to MAGED4 heterogeneity in OSCC and highlight the potential of combination epigenetic therapies to reverse this heterogeneity, thereby providing a foundation for exploring such approaches to improve immunotherapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, School of Basic Medicine Science, Guangxi Medical University, Nanning 530021, China.
- General Practice School, Guangxi Medical University, Nanning 530021, China.
- Key Laboratory of Basic Research on Regional Diseases (Guangxi Medical University), Education Department of Guangxi Zhuang Autonomous Region, Nanning 530021, China.
- Guangxi Health Commission Key Laboratory of Basic Research on Brain Function and Disease, Nanning 530021, China.
ORCID-Profile: Huan Xie
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Province
- Guangxi Young and Middle-aged University Teachers’ Scientific Research Ability Enhancement Project
- Youth Science Foundation of Guangxi Medical University
- Innovation and Entrepreneurship Training Program Project for College Students in Guangxi Medical University
Zitieren
APA
Xie, H., Li, F., Zou, X., Yu, X., Zhang, S., Wang, Y., Nong, W., Xie, L., Wang, Y., Luo, B., Xie, X., & Zhang, Q. (2025). Intratumoral Heterogeneity of MAGED4 Expression in Oral Squamous Cell Carcinoma: Epigenetic Mechanisms and Therapeutic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411772
Vancouver
Xie H, Li F, Zou X, Yu X, Zhang S, Wang Y, et al. Intratumoral Heterogeneity of MAGED4 Expression in Oral Squamous Cell Carcinoma: Epigenetic Mechanisms and Therapeutic Implications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411772
BibTeX
@article{Xie2025,
author = {Xie, Huan and Li, Feng and Zou, Xiaoqiong and Yu, Xiaoqing and Zhang, Sheng and Wang, Yanjing and Nong, Weixia and Xie, Limin and Wang, Yi and Luo, Bin and Xie, Xiaoxun and Zhang, Qingmei},
title = {Intratumoral Heterogeneity of MAGED4 Expression in Oral Squamous Cell Carcinoma: Epigenetic Mechanisms and Therapeutic Implications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411772}
}
EUVIMED